Edition:
United States

Profile: Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

3.60DKK
18 Aug 2017
Change (% chg)

kr.0.02 (+0.56%)
Prev Close
kr.3.58
Open
kr.3.58
Day's High
kr.3.61
Day's Low
kr.3.54
Volume
5,480
Avg. Vol
23,586
52-wk High
kr.4.49
52-wk Low
kr.2.20

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous system (CNS) diseases and acts as a dopaminergic stabilizer; and Ordopidine, a medicine, which also is involved in the CNS disease treatment as a dopaminergic stabilizer. Furthermore, the Company operates through three wholly owned subsidiaries, NeuroSearch Sweden AB, Poseidon Pharmaceutical A/S and NsExplorer A/S, as well as through affiliates, such as Atonomics A/S and NsGene A/S.

Company Address

Neurosearch A/S

Strandvejen 60
HELLERUP     2900
P: +4544.608000
F: +4544.608080

Company Web Links